Encore Medical, Inc. (EMI)

Encore Medical will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
3,000,000
Deal Size
$15.00M
Chart not available yet
Data will show when the stock starts trading.
Market Cap48.72M
Revenue (ttm)2.10M +48.8%
Net Income-1.58M
EPS-0.16
Shares Out 9.74M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About EMI

Encore Medical is a structural heart device company dedicated to the transcatheter closure of certain cardiac defects.We develop, manufacture, and market septal occlusion products, which are small, implantable devices delivered through a catheter inserted into a major blood vessel to permanently repair certain cardiac defects. Our devices include patented technology that has been in use extensively outside of the U.S. Procedures are performed in a cardiac catheterization lab and reduce the need for open heart surgery or a lifetime of drug thera... [Read more]

Sector Healthcare
Founded 2017
Employees 16
Stock Exchange NYSEAMERICAN
Ticker Symbol EMI
Full Company Profile

Financial Performance

Financial Statements

News

Encore Medical Starts U.S. IPO Process

Encore Medical, Inc. seeks $17.25 million in IPO funding to support US FDA trials for its heart defect closure device. EMI has CE Mark approval in the EU but limited recent sales; US clinical trial co...

4 months ago - Seeking Alpha

Cardiac implant developer Encore Medical files for a $17 million IPO

Encore Medical, which makes transcatheter implants to repair cardiac defects, filed on Monday with the SEC to raise up to $17 million in an initial public offering.

5 months ago - Renaissance Capital

Encore Medical IPO Registration Document (S-1)

Encore Medical has filed to go public with an IPO on the NYSE American.

5 months ago - SEC